Amaxa’s Nucleofector technology is a highly efficient non-viral method for transfection, based on two components: the Nucleofector device that delivers unique electrical parameters and Nucleofector kits that contain cell-type-specific Nucleofector solutions.
The electrical parameters of the Nucleofector are claimed to be different from other electroporation devices. Each electrical setting is displayed as a distinct program which has been adapted to the requirements of a particular cell type. Electrical parameters are preprogrammed into the Nucleofector, thus optimisation by the user is not necessary.
The device weighs 2.6 kg and is sized to fit under a sterile hood, suitable for sterile work with cells.
Phone: 1300 657508
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
Immundiagnostik ID-Vit MTP assays
Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...
Bertin Bioreagent obesity research ELISA kits
Bertin Bioreagent's obesity research ELISA kits include targets for 20-hydroxyecdysone,...
Learn More
I am interested in Amaxa Nucleofector device.
Complete the form and a supplier representative will be in touch.
